Posted on

medical mary cbd cream

Clyde Griffin (verified owner) – December 23, 2020

Bill Bell (verified owner) – December 15, 2020

Finally got my cbd pain relief cream for myself and am giving my feedback. I didn’t want to take prescription pain meds. I must share that my pain problem isn’t ruining my spirit anymore. I trust this brand over others I’ve tried. Gave me the relief I needed.

Medical Mary CBD Massage Oil (Lavender) – 100mg

Already have an account? Log In

Calvin Sanchez (verified owner) – December 4, 2020

Jorge Mcdonald (verified owner) – December 4, 2020

I bought CBD muscle cream (my husband uses it too). I’ve had problems and wasn’t sure what to do. It’s good to say my muscle pain made me feel like I had no friends. I started feeling better within an hour. Super happy with my purchase 🙂

“We’re not just an arm or a leg, we’re not just obese or a diabetic or a pain sufferer,” Melton said. “How do we treat you as a whole person?”

As the pandemic unevenly roars on, Emily Melton, founder and managing partner of Threshold VC, is reflecting on a previous public health crisis: the Spanish flu.

Enter personalized medicine. The buzzy yet powerful framing is growing in popularity among Silicon Valley startups. It’s a delivery system in which patients receive more holistic care that takes into account multiple symptoms or comorbidities. In hormonal health, for example, personalized medicine could add more data and specificity to which birth control someone takes, instead of the usual process of trial and error. Essentially, it’s the opposite of interventional medicine.


Avi Dorfman says going direct to consumers is the most effective way to treat chronic pain, so he founded Clearing. The digital health startup worked with a medical advisory board of physicians and researchers from Harvard, Johns Hopkins and NYC’s Hospital for Special Surgery to create an opioid-free solution for people struggling with pain.

She says the response just over a century ago prompted the rise of interventional medicine — treating illness through surgery or medicine only after symptoms manifest. Today, interventional medicine is the dominant mindset in Western healthcare. And, Melton, a lead investor in health tech startups including Livongo, Tia and Calibrate, says the care pathway ages well.

Last month, Clearing raised a $20 million seed round led by Bessemer and Founders Fund. Melton also invested in the round on behalf of Threshold.

A number of companies are using this approach to reinvent care for patients with musculoskeletal (MSK) medical conditions and chronic pain. These conditions are commonly treated with addictive opioids, a major public health concern. As an estimated 50 million Americans suffer from chronic pain, entrepreneurs are working on solutions that don’t resemble the cookie-cutter status quo. And the money market is certainly there: In 2017, the global MSK medical market was valued at $57.4 billion; the market for chronic pain, which overlaps with MSK medicine, is expected to hit $151.7 billion in value by 2030.